Skip to content

ECM

Eye Health News

  • Home
  • Conjunctivitis
  • Glaucoma
  • Cataract Surgery
  • Blog
SUNY College of Optometry Appoints Dr. Melissa Trego as Vice President and Dean for Academic Affairs NEW YORK—SUNY College of Optometry has announced the appointment of Melissa E. Trego, OD, Ph.D., as vice president and dean for academic affairs, effective this June. A seasoned educator, clinician, and a national leader in optometric education, Dr. Trego will oversee all optometric academic programming at the college including curriculum development, residency programs, accreditation, faculty…EYECAREMay 16 2025
Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update RESEARCH TRIANGLE PARK, N.C.—Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company developing new therapies for the treatment of inherited retinal diseases and other ophthalmic disorders, has announced financial results for the first quarter ended March 31, 2025, and provided a corporate update.EYECAREMay 16 2025
Grants Now Available for Students, Residents to Attend Neuro-Optometric Rehabilitation Association's 2025 Annual Conference LOUISVILLE, Ky.—The Neuro-Optometric Rehabilitation Association, International (NORA) announced that it is offering up to 10 students and residents with an interest in neurorehabilitation an opportunity to apply for a student grant to attend its 2025 Annual Conference from September 18-21, 2025, in Denver, Colo.EYECAREMay 16 2025
Staffing Woes Tied to Physician Burnout Nearly half of physicians surveyed reported burnout and said they sometimes worked on incompletely staffed teams.EYECAREMay 15 2025
As Drug Overdose Deaths Decline, Experts Worry About Future Drug overdose deaths declined by almost 27% in 2024, new provisional data from the US Centers for Disease Control and Prevention (CDC) showed. The decline continues a downward trend that began in 2023, with a 3% decline that year, followed by steady drops each month of 2024.EYECAREMay 15 2025
National Vision’s Alex Wilkes and Reade Fahs Discuss the Company's Growth and Transformation in an Exclusive VMAIL Interview VMAIL recently sat down with National Vision’s Alex Wilkes, president, and Reade Fahs, CEO, for an exclusive interview to discuss the continued growth and ongoing transformation initiatives that have kept the company at the forefront of the industry. Wilkes, who joined National Vision as president in August of last year, will succeed Fahs as CEO…EYECAREMay 15 2025
Alcon Reports First Quarter 2025 Financial Results and Updated Full-Year Guidance GENEVA, Switzerland—Alcon (SIX/NYSE:ALC), a global leader in eyecare, has announced its financial results for the three months ending March 31, 2025. For the first quarter of 2025, sales were $2.5 billion, flat on a reported basis and up 3 percent on a constant currency basis, as compared with the same quarter of the previous year,…EYECAREMay 15 2025
VSP Vision Receives 2025 US Best Managed Company Gold Standard Award for Fifth Consecutive Year RANCHO CORDOVA, Calif.—VSP Vision announced it has been selected as a 2025 US Best Managed Company Gold Standard award winner, marking the company’s fifth consecutive year of being recognized for its commitment to excellence.EYECAREMay 15 2025
Clearside Biomedical Reports First Quarter 2025 Financial Results and Provides Corporate Update ALPHARETTA, Ga.—Clearside Biomedical, Inc., a biopharmaceutical company developing therapies for the back of the eye through the suprachoroidal space (SCS), has announced its financial results for the first quarter ending March 31, 2025, and provided a corporate update.EYECAREMay 15 2025
Doheny Eye Institute Announces Kaustabh Ghosh, Ph.D. as the Mary D. Allen Endowed Chair in Vision Research PASADENA, Calif.—Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, has announced that Kaustabh Ghosh, Ph.D., has been awarded the Mary D. Allen Endowed Chair in Vision Research, a faculty position supported by the generous gift made to the Institute by Mrs. Allen in 1990.EYECAREMay 15 2025
Americans Worry About Trump Administration’s Handling of Current Measles Outbreak, Reuters/Ipsos Poll FindsAmericans worry about President Donald Trump's administration's ability to contain an ongoing outbreak of measles, while the vast majority of them believe that vaccines for the disease are safe, according to a new Reuters/Ipsos poll.EYECAREMay 14 2025
Living Near a Golf Course Linked to Parkinson’s, New Study ShowsGolf season is here, bringing joy and exercise to many. But new research has linked the links to a dangerous health risk, particularly for those living nearby. People residing within 3 miles of a course faced a greater risk of developing Parkinson’s disease, the new study shows. EYECAREMay 14 2025
Yes, You Can Die From a Broken HeartWelcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr. F. Perry Wilson from the Yale School of Medicine. A patient comes crashing into the emergency room with severe chest pain.EYECAREMay 14 2025
Carl Zeiss Meditec Reports Revenue Growth and Stable Operating Profit in First Half of Fiscal YearJENA, Germany—Leading medical technology company Carl Zeiss Meditec AG (ISIN: DE0005313704) has announced financial results for the first six months of its 2024/2025 fiscal year ending March 31, 2025. The company reported revenue of €1,050.5 million during the period, compared with €947.2 million in the prior year, corresponding to growth of 10.9 percent. Adjusted for…EYECAREMay 14 2025
The Alliance for Healthcare from the Eye Launches to Transform Disease Detection and Coordinated Care Delivery With Oculomics and AISALT LAKE CITY—A coalition of health care leaders has announced the launch of the Alliance for Healthcare from the Eye (AHE), a cross-sector initiative aimed at harnessing the eye as a gateway to both ocular and systemic health through artificial intelligence (AI), a field known as oculomics. This consortium of health systems, clinicians, industry innovators,…EYECAREMay 14 2025
VSP Global Innovation Center Releases New Report on ‘The Future of Oculomics’RANCHO CORDOVA, Calif.—VSP Vision has announced the release of “The Future of Oculomics,” the latest installment in its Futurist Report series from the VSP Global Innovation Center that explores how the eye’s connection to the rest of the human body elevates eyecare in the broader health care continuum, the company noted.EYECAREMay 14 2025
The Vision Council's Research Webinar Reveals Trends in Managed Vision CareALEXANDRIA, Va.—Satisfaction with eyecare insurance plans is divided among Americans, according to the latest data from The Vision Council. The organization provided an overview of the findings of its report, Focused inSights 2025: Managed Vision Care, during a webinar last week, which explored overall satisfaction with managed vision care programs (MVC). In March, VMAIL reported…EYECAREMay 14 2025
West Virginia Bill Allows ODs to Provide Optometric Laser Surgery, Expanding Scope of PracticeCHARLESTON, W.Va.—A new bill that recently passed in West Virginia has expanded optometric scope of practice in most areas of the state, allowing doctors of optometry to provide a broader range of services, including laser surgery, while helping address critical access issues, according to an announcement from the American Optometric Association.EYECAREMay 14 2025
Pros and Cons of AI Patient Portal MessagesBetween increased administrative burdens and an influx of patient messages, many primary care physicians (PCPs) are turning to generative artificial intelligence (AI) tools to help draft patient portal messages. A new study suggests those tools can help—but they may also introduce dangerous errors that physicians fail to catch.EYECAREMay 13 2025
CT Scans and Radiation Risk: What to Say to Your DoctorIf you’ve ever hesitated before getting a CT scan, you’re not alone. A recent study linked 5% of all new cancer cases to radiation exposure from CT scans—a finding that’s raised concern among patients. But experts say avoiding a CT scan when you need one can be dangerous.EYECAREMay 13 2025
PECAA Gives Celebrates 10th Anniversary With Record Donation to Orlando NonprofitBOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) members, strategic vendor partners, industry leaders and employees donated more than $41,000 to Orlando youth literacy program Page 15 during the 2025 PECAA Annual Meeting held in Orlando from April 9-11, 2025, the group announced.EYECAREMay 13 2025
SUNY Optometry Announces Commencement Speaker and Honorary Degree Recipients for 2025 Graduation CeremonyNEW YORK—SUNY College of Optometry has announced that its 2025 commencement ceremony will feature a keynote address from assemblywoman Alicia L. Hyndman, a lifelong advocate for education, equity, and economic opportunity in New York.EYECAREMay 13 2025
U.S. and China Agree to Tariff Reductions and 90-Day Pause, Is Relief on the Way for the Optical Industry?NEWARK, N.J.—In a dramatic turn of events, major news outlets reported on May 12 that the U.S. and China have each announced temporary and significant reductions in import tariff rates, bringing measurable reprieve for now in a trade war that has roiled industries and brought about stomach-churning instability to domestic and global markets. A White…EYECAREMay 12 2025
Which Doctors See the Fewest Patients per Hour?A recent report was released on the average number of patients seen per hour by specialty, which ranges from 1 to over 15.EYECAREMay 12 2025
The FDA Approves First U.S. at-Home Tool as a Pap-Smear AlternativeThe Food and Drug administration has approved the U.S.'s first at-home alternative to the Pap smear, a procedure generations of women have dreaded and often found painful.EYECAREMay 12 2025
ARVO Attendees Hear Call to Save National Eye InstituteAdvocates for eye and vision research must come together now to thwart attempts by the Trump administration to slash research funding and downgrade and dilute the National Eye Institute (NEI) of the National Institutes of Health (NIH), researchers and clinical trial investigators were told at the Association for Research in Vision and Ophthalmology (ARVO) 2025…EYECAREMay 12 2025
The Vision Council Takes Action in Washington to Advocate for Vision Care Access and Optical Industry StabilityALEXANDRIA, Va.—The Vision Council has provided updates on the action it is taking on Capitol Hill to advocate for practical, pro-business solutions that preserve access to vision care and support the continued success of the optical industry in the face of evolving trade and regulatory challenges, according to an announcement from the organization. As tariff…EYECAREMay 12 2025
Zyloware Encourages ECPs to Celebrate National Eyewear Day on June 6PORT CHESTER, N.Y.—Zyloware is inviting all eyecare professionals and eyewear enthusiasts to once again join the company in celebration of the 10th annual National Eyewear Day on Friday, June 6, 2025. Each year, Zyloware celebrates National Eyewear Day by promoting tips, tools and philanthropic initiatives that bring awareness to comprehensive eye exams and overall eye…EYECAREMay 12 2025
Harrow Announces First Quarter 2025 Revenue GrowthNASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, has announced results for the first quarter ended March 31, 2025. The company reported revenue of $47.8 million for the first quarter of 2025, a 38 percent increase compared with $34.6 million in the prior-year period. Vevye revenues grew to $21.5 million, a 35…EYECAREMay 12 2025
Prevent Blindness Cheers the Reintroduction of ‘Early Detection of Vision Impairments for Children Act’CHICAGO—Nonprofit eye health and advocacy organization Prevent Blindness has announced its support for the reintroduction of the Early Detection of Vision Impairments for Children Act (EDVI) in the U.S. House of Representatives (H.R. 2527).EYECAREMay 12 2025
Registration Is Now Open for Neuro-Optometric Rehabilitation Association's 2025 ConferenceLOUISVILLE, Ky.—The Neuro-Optometric Rehabilitation Association, International (NORA), a global advocate for advancing neurovisual rehabilitation, announced that it has opened registration for its 35th Annual Conference, taking place September 18–21, 2025, at the Hilton Denver City Center in Denver, Colo.EYECAREMay 12 2025
Healthy Vision Month Encourages Individuals of All Ages to Prioritize Eye HealthApproximately 37 million adults in America have age-related macular degeneration, cataract, diabetic retinopathy, or glaucoma, all of which can cause visual impairment or blindness, according to the American Academy of Ophthalmology (AAO). With these statistics in mind, however, they advise that there are simple things patients can do to take charge of their eye health,…EYECAREMay 09 2025
TIME Reveals the 2025 TIME100 Health List of the World’s Most Influential People in HealthLast week, TIME revealed the second annual TIME100 Health list recognizing the 100 most influential individuals in health.EYECAREMay 09 2025
U.S. Surpasses 1,000 Measles Cases in 2025, Second Worst Year Since Disease Was Declared EliminatedMore than 1,000 measles cases have been reported in the United States in 2025, according to a CNN tally. This is only the second year cases have been this high since the disease was declared eliminated in the U.S. a quarter-century ago, and a large multistate outbreak continues to grow, putting the nation on track…EYECAREMay 09 2025
Multiple Cancers Occurring More Often in Younger Age GroupsThe frequency of early-onset cancer has increased for multiple types of malignancies, for reasons that remain unclear, a 10-year review of national statistics showed.EYECAREMay 09 2025
Maximilian Foerst Named as President and CEO of Carl Zeiss Meditec AG, to Succeed Dr. Markus WeberJENA, Germany—Leading medical technology company Carl Zeiss Meditec AG has announced the appointment of Maximilian Foerst as the company’s new president and CEO, effective June 1, 2025. Foerst, who joined Zeiss Group in 1995 and has been head of Zeiss Greater China since 2009, will succeed Carl Zeiss Meditec AG’s current president and CEO Dr.…EYECAREMay 09 2025
Warby Parker Reports Double-Digit Revenue Growth in First Quarter of 2025NEW YORK—Warby Parker Inc. (NYSE: WRBY) has announced financial results for the first quarter ended March 31, 2025, reporting that net revenue increased $23.8 million, or 11.9 percent, to a reported $223.8 million, compared with the prior-year period. The company also reported that its first quarter 2025 earnings included a $3.5 million net profit, its…EYECAREMay 09 2025
OneSight EssilorLuxottica Foundation, LensCrafters, and Operation Eyesight Universal Collaboration Brings Eye Exams and Glasses to Children in Maskwacîs, CanadaMASKWACÎS, Alberta—To help students with undiagnosed vision issues, LensCrafters optometrists and team members recently came together to provide eye exams and glasses to children in Maskwacîs, Alberta, Canada. The clinic, which was held April 28 through May 2 at the Nipisihkopahk Elementary School in partnership with the Maskwacîs Education Schools Commission, was organized by LensCrafters,…EYECAREMay 09 2025
RxSight, Inc. Reports 28 Percent Revenue Growth in First Quarter 2025, Reiterates Full-Year GuidanceALISO VIEJO, Calif.—RxSight, Inc., an ophthalmic medical device company providing customized vision to patients following cataract surgery, has reported financial results for the first quarter for the period ending March 31, 2025.EYECAREMay 09 2025
Sight Sciences Announces First Quarter 2025 RevenuesMENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, has announced financial results for the first quarter ended March 31, 2025, reporting first quarter 2025 total revenue of $17.5 million, a decrease of 9 percent compared with the same period in the prior year.EYECAREMay 09 2025
Small Businesses Are Reassessing Their Strategies in Response to an Evolving Business EnvironmentAmerican Express has released its latest Amex Trendex: Small Business Edition, which shows that small businesses are reassessing their business strategies in response to new customer behaviors and an evolving business environment. Surveying over 1,000 small businesses in the U.S. from March 24–30, 2025, the Trendex report found that 92 percent of small businesses expect…EYECAREMay 08 2025
Science Reveals 4 New Ways to Lower Your Dementia RiskThe list of ways to reduce your dementia risk just keeps getting longer. Some are big efforts (meditation or distance running), while others are small (gardening, walking, eating blueberries). EYECAREMay 08 2025
New Pacemaker Smaller Than a Grain of RiceThe future of cardiac pacing may boil down to a single grain of rice. Engineers at Northwestern University in Chicago have developed a biodegradable pacing device so small it can be injected by needle into the heart muscle of newborn babies.EYECAREMay 08 2025
National Vision Reports Revenue Growth in First Quarter 2025, Raises Fiscal OutlookDULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., reported its financial results for the first quarter ended March 29, 2025. Net revenue increased 5.7 percent to $510.3 million compared with the prior-year period, and was primarily driven by what the company said was adjusted comparable store…EYECAREMay 08 2025
STAAR Surgical Reports First Quarter 2025 ResultsLAKE FOREST, Calif.—STAAR Surgical Company, a leading developer of phakic intraocular lenses with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has reported results for the first quarter ended March 28, 2025.EYECAREMay 08 2025
VSP Vision Earns 2025 Great Place To Work Certification for Second Consecutive YearRANCHO CORDOVA, Calif.—VSP Vision has announced it is once again certified by Great Place To Work for a second consecutive year. The award is based entirely on what current employees say about their experience working at VSP Vision.EYECAREMay 08 2025
EyePoint Pharmaceuticals Announces First Quarter 2025 Financial ResultsWATERTOWN, Mass.—EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and a developer of therapeutics for patients with serious retinal diseases, has announced financial results for the first quarter ended March 31, 2025.EYECAREMay 08 2025
Time Is Running Out—The Nomination Deadline for Jobson’s Ultimate Partners Program Is Today, May 8NEWARK, N.J.—The deadline to nominate a supportive business partner for Jobson’s Ultimate Partners Program is today, May 8, at 11:59 p.m. ET. The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners program. Now in its fifth year, Jobson’s 2025 Ultimate Partners program allows readers…EYECAREMay 08 2025
Legislation Would Enhance Vision and Medical Eyecare in MaineI’ve been a practicing optometrist in Bangor for 36 years. During that time, I’ve witnessed many changes in state laws, which have allowed optometrists to better serve our patients. Almost four years ago, my daughter, Dr. Chloe Douglass, joined my practice, which has allowed us to increase the number of patients who receive care. This…EYECAREMay 07 2025
How to Accept When Stress Is Too Much (and What to Do Next)A few years back, my dad was near end-of-life, my marriage was on the rocks, and I was training for the Boston Marathon. It was a lot to deal with—emotionally and physically. I ended up injured and never saw the start line. Our bodies can't tell one type of stress from another. Exceed your limits,…EYECAREMay 07 2025
Majority of Public Opposes GOP Plan for Medicaid Cuts, Poll SaysLarge majorities of Americans, including Republicans, oppose federal funding cuts to Medicaid, according to a poll from health policy research group KFF.EYECAREMay 07 2025
Vision Source Exchange 2025 Welcomes Over 3,000 Attendees, Champions OD Leadership and Bold Future of Private Practice OptometryDENVER, Colo.—Vision Source, a North American network of independent private practice optometrists, welcomed more than 3,000 member doctors, staff and industry partners to The Exchange 2025, its annual event, held this year in Denver, Colorado, from April 30 through May 3. For 2025, The Exchange was themed “Ascend,” and celebrated a renewed mission to elevate…EYECAREMay 07 2025
Tarsus Pharmaceuticals Reports First Quarter 2025 Sales GrowthIRVINE, Calif.—Tarsus Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced financial results for the first quarter ended March 31, 2025. Net product sales were reported at $78.3 million compared with $24.7 million for the same period in 2024.EYECAREMay 07 2025
Out-of-Pocket Drug Spending Hit $98 Billion in 2024, Report SaysAmericans spent $98 billion out of pocket on prescription drugs in 2024, marking a cumulative 25 percent increase over five years, according to an annual report from analytics firm IQVIA.EYECAREMay 06 2025
Parents' Tech Use May Take a Toll on Their KidsParents being glued to their devices may negatively impact their children's health and development, according to a systematic review and meta-analysis.EYECAREMay 06 2025
Fielmann Group Reports Sales Growth for Full-Year 2024 and First Quarter of 2025, Forecasts Continued GrowthHAMBURG, Germany—Global eyewear provider The Fielmann Group (ETR:FIE) has reported its audited fiscal year 2024 financials, in line with guidance and preliminary figures published in March. The report demonstrates consolidated sales of €2.3 billion in 2024, a 15 percent increase compared with the previous year (€2.0 billion), despite what the company noted as macroeconomic headwinds…EYECAREMay 06 2025
Ocular Therapeutix Reports First Quarter 2025 Revenue ResultsBEDFORD, Mass.—Ocular Therapeutix, Inc., a fully integrated biopharmaceutical company, has reported financial results for the first quarter ended March 31, 2025. Total net revenue was $10.7 million for the first quarter of 2025.EYECAREMay 06 2025
Chicago College of Optometry’s Dr. Parres M. Wright Selected for National Eye Health Education Program Planning GroupDOWNERS GROVE, Ill.—Midwestern University has announced that Parres M. Wright, OD, FAAO, associate professor and clinic care lead at the Chicago College of Optometry, has been appointed to the National Eye Health Education Program (NEHEP) Planning Group under the National Eye Institute, part of the National Institutes of Health.EYECAREMay 06 2025
Rates of Blindness Increasing, With Experts Citing Aging Population and Access to Care as Key FactorsBlindness is on the rise in the U.S., with more than one million Americans diagnosed as of 2021, according to a study published in JAMA Ophthalmology titled, Prevalence of Visual Acuity Loss or Blindness in the U.S. In addition to the more than 1 million Americans who are blind, more than 7 million people are…EYECAREMay 05 2025
Is Now a Bad Time for Doctors to Retire?The stock market is down. Then up. Then down. And up again. But overall, it is mainly down. Most economic markers trend the same way. And, unfortunately, no one has a crystal ball. But there is certainly broad concern over the less-predictable-than-usual nature of the market of late. This has led many seasoned doctors to…EYECAREMay 05 2025
Expect Increases in Foodborne IllnessGrowing up, “food poisoning,” to me, meant throwing up repeatedly after eating the mayo-based potato salad several hours after it was put on the picnic table on July 4. But that version (probably Staphylococcus aureus–toxin mediated) is not the most common form. U.S. data from 2024 showed 1,392 bacterial caused foodborne illnesses from contaminated food,…EYECAREMay 05 2025
VSP Vision Names Scott Nehs Chief Legal OfficerRANCHO CORDOVA, Calif.—VSP Vision announced today that Scott Nehs has been appointed chief legal officer (CLO) and general counsel, effective immediately. Nehs is responsible for all legal affairs for the company’s lines of business, including regulatory compliance, government affairs and corporate risk management, the company stated. He reports to Michael Guyette, president and CEO of…EYECAREMay 05 2025
Topcon Healthcare Acquires RetInSight to Accelerate AI-Powered Imaging Innovation in EyecareLA JOLLA, Calif.—Topcon Healthcare, Inc., a provider of medical devices and digital health care solutions, has announced the acquisition of RetInSight GmbH, a privately held company based in Vienna, Austria, specializing in retinal imaging AI solutions. According to the announcement, the move advances Topcon Healthcare’s vision of Healthcare from the Eye, enhancing access to intelligent…EYECAREMay 05 2025
Transitions Certification Program Updated With New Education OpportunitiesPINELLAS PARK, Fla.—Transitions Optical is inviting eyecare professionals to earn or renew their Transitions Expert status through a refreshed Transitions Certification Program, which includes live training opportunities, updated content and access to new offerings from Transitions, the company announced.EYECAREMay 05 2025
Registration Now Open for American Academy of Optometry’s Annual Meeting in Boston on Oct. 8-11BOSTON—Registration is now open for Academy 2025 Boston, the American Academy of Optometry’s annual meeting, to be held Oct. 8-11, 2025 at the Boston Convention and Exhibition Center. The annual event offers more than 300 hours of clinically relevant CE, ranging from hands-on workshops to impactful symposia.EYECAREMay 05 2025
Rates of Blindness Increasing, With Experts Citing Aging Population and Access to Care as Key FactorsBlindness is on the rise in the U.S., with more than one million Americans diagnosed as of 2021, according to a study published in JAMA Ophthalmology titled, Prevalence of Visual Acuity Loss or Blindness in the U.S. In addition to the more than 1 million Americans who are blind, more than 7 million people are living…EYECAREMay 02 2025
Nasal Powder for Acute Migraine Gets FDA NodThe FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, Satsuma Pharmaceuticals announced Wednesday.EYECAREMay 02 2025
FDA Approves New Monoclonal Antibody for Myasthenia GravisThe U.S. Food and Drug Administration (FDA) has approved nipocalimab-aahu (Imaavy, Johnson & Johnson) for the treatment of generalized myasthenia gravis (gMG) in adults and adolescents 12 years of age and older, the company announced in a statement.EYECAREMay 02 2025
Hoya Reports Revenue Growth in 2024 Fourth Quarter and Full-Year, Cautions of Possible Impact From TariffsTOKYO—Hoya Corporation (7741:Tokyo) has announced consolidated revenue of 216.8 billion yen for the fourth quarter ending March 31, 2025, up 10.1 percent from the same period in 2024, and up 11 percent on a constant currency basis. Operating profit increased due to continued efficient operations around production in the IT business and improved profitability in…EYECAREMay 02 2025
Zyloware Announces Strategic Measures to Mitigate U.S. Tariffs' ImpactPORT CHESTER, N.Y.—As the U.S. trade environment continues to evolve, Zyloware, a long-running family-owned eyewear company, said it is proactively implementing strategic measures to offset the potential impact of newly imposed tariffs on imported optical goods. The company stated that its top priority remains unchanged: to protect the value and continuity of its partnerships with…EYECAREMay 02 2025
The Vision Council Launches Campaign for 2025 National Sunglasses DayALEXANDRIA, Va.—The Vision Council Foundation has announced the launch of its 2025 National Sunglasses Day campaign leading up to the annual celebration on June 27. This year’s campaign includes fresh resources, exclusive events and new opportunities for public engagement, The Vision Council said, reinforcing the importance of UV-protective eyewear for long-term eye health. National Sunglasses…EYECAREMay 02 2025
Eyecare Republic Adds EDGEPro by GPN Technologies to Its Vendor NetworkPLANO, Texas—Eyecare Republic (ECR), a nationwide community of independent optometrists, has added EDGEPro by GPN to its network of vendor relationships, according to an announcement from Eyecare Republic.EYECAREMay 02 2025
Foundation Fighting Blindness and Alma Partner to Provide Mental Health Support for Blind and Low Vision IndividualsCOLUMBIA, Md.—The Foundation Fighting Blindness (FFB), a private funding source for retinal degenerative disease research, announced a national partnership with mental health network Alma, to provide personalized mental health therapy to individuals who are blind or have low vision.EYECAREMay 02 2025
New England College of Optometry Announces 2025 Commencement HonoreesBOSTON—The Board of Trustees at New England College of Optometry (NECO) has announced the distinguished honorees for its 131st commencement exercises, scheduled to take place on May 18, 2025, at Boston’s Symphony Hall.EYECAREMay 02 2025
Could Measles Become Endemic?WebMD reports that a new study suggests measles could become endemic again. Head over to WebMD for more.EYECAREMay 01 2025
WHO Member Countries Agree on a Draft ‘Pandemic Treaty’ to Try to Avoid COVID-19 MistakesLONDON—Five years after COVID-19 triggered national lockdowns, economic uncertainty and killed millions, the World Health Organization’s member countries agreed on a draft “pandemic treaty” that sets guidelines for how the international community might confront the next global health crisis.EYECAREMay 01 2025
Hospitals Begin to Grapple With Tariff FalloutHospitals across the country are starting to reckon with the effects President Trump's tariffs are having on medical supplies like syringes and PPE, and in some cases freezing spending and making other contingencies.EYECAREMay 01 2025
Bausch + Lomb Reports 3 Percent Revenue Growth in 2025 First Quarter and Updates Full-Year Guidance After IOL Recall; Faces Tariff ChallengesVAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced its first quarter 2025 financial results, demonstrating total reported revenue of $1.137 billion, as compared with $1.099 billion in the first quarter of 2024, an increase of $38 million, or 3 percent. Excluding the unfavorable impact of foreign exchange of $19 million,…EYECAREMay 01 2025
datosX and Topcon Healthcare Form Strategic Partnership to Accelerate Digital Health InnovationSAN FRANCISCO and LA JOLLA, Calif.—datosX Digital Health Labs, a leader in digital health technology (DHT) testing and real-world validation for DHTs, has announced it is entering into a strategic partnership with Topcon Healthcare, Inc., a provider of medical devices and digital health care solutions. The initial investment in datosX Digital Health Labs, led by…EYECAREMay 01 2025
CORE to Expand Scope, Integrate Into Waterloo Eye Institute and Welcome New Steering CommitteeWATERLOO, Ontario—The Centre for Ocular Research and Education (CORE), the largest research center at the University of Waterloo School of Optometry and Vision Science, is expanding its scope, the university announced, as it applies its nearly 40 years of research experience to a broader range of fields and integrates into the Waterloo Eye Institute (WEI).…EYECAREMay 01 2025
Glaukos Reports 25 Percent Net Sales Increase in 2025 First Quarter, Reaffirms Full-Year GuidanceALISO VIEJO, Calif.—Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, has announced financial results for the first quarter ended March 31, 2025.EYECAREMay 01 2025
Prevent Blindness Designates May as Its Second Annual Inherited Retinal Disease and Genetic Testing MonthCHICAGO—Prevent Blindness, a nonprofit eye health organization, has designated May as its second annual Inherited Retinal Disease (IRD) and Genetic Testing Month, according to an announcement from the organization.EYECAREMay 01 2025
Review of Optometry: Take on Advanced Corneal Care TechniquesThe ability to restore and protect vision is one of the most powerful aspects of optometric care, and nowhere is this more evident than in management of corneal disease. Corneal conditions—such as keratoconus, corneal infections and dystrophies—can significantly affect a patient’s vision and overall quality of life. Optometrists who choose to subspecialize in corneal care…EYECAREApr 30 2025
More and More Older Americans Want to Know Their Alzheimer's Status, Survey FindsOlder Americans want to know if they are in the early stages of Alzheimer's disease and would happily take a blood test to find out, according to a national survey.EYECAREApr 30 2025
Gen Z Is Leading a New Weight Loss Trend: Ozempic MicrodosingAs Ozempic use skyrockets across America, Generation Z is fueling a new weight loss trend, according to a new survey from healthcare software company Tebra.EYECAREApr 30 2025
This New Treatment Is Transforming Prostate Cancer CareProstate cancer is the second-deadliest cancer among U.S. men—and it's on the rise. More than 300,000 men are diagnosed with the condition each year, a number that's been climbing by 3% annually since 2014, according to the American Cancer Society.EYECAREApr 30 2025
Warby Parker Publishes 2024 Annual Report, Will Release 2025 First Quarter Financial Results on May 8NEW YORK—Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand focused on vision for all, has released its annual report for 2024. According to the announcement, 2024 marked Warby Parker’s 15th year in business. The company’s next earnings call, reporting on the first quarter of 2025, is scheduled for May 8 at 8:00 a.m. ET.…EYECAREApr 30 2025
Azalea Vision Raises €9 Million in First Closing of Series A Funding; Appoints Robert J. Dempsey as Chairman of the BoardGHENT, Belgium—Azalea Vision, a health tech company developing a platform for medical-grade smart lenses that sense, adapt and interact in real time, scaling from vision correction to biosensing and diagnostics, announced that it raised €9 million during the first closing of its €15 million Series A funding round. As part of the company’s strategy for…EYECAREApr 30 2025
National Vision Appoints Alex Wilkes as CEO, Reade Fahs to Serve as Executive ChairmanDULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., announced early this morning that Alex Wilkes has been appointed as the company’s next CEO, effective August 1, 2025. He will join the company’s board of directors at that time. Wilkes, who joined the company as president in…EYECAREApr 29 2025
Some Adults May Need a Measles Booster Shot. Who Should Get One and Why?Measles, once considered eliminated in the United States, has been making an unfortunate comeback. With recent outbreaks in various states, health experts are urging some adults to check their vaccination status. While most people are protected, some may need a booster shot to ensure they remain immune.EYECAREApr 29 2025
Unhealthy Sleep Patterns, Duration Linked With ObesityUnhealthy sleep patterns and shorter sleep duration both correlated with obesity occurrence in American adults, suggesting that interventions to promote healthy sleep habits could help reduce the risk of obesity, according to a study published in BMC Public Health.EYECAREApr 29 2025
How Higher Tariffs Could Impact Health InsurersWhile health plans are not likely to feel the most acute effects from the Trump administration's tariffs, they face downhill impacts from market volatility and rising costs, according to a new analysis from Fitch Ratings.EYECAREApr 29 2025
Topcon Healthcare Appoints Dr. Daniela Ferrara to the Role of Chief Medical OfficerLA JOLLA, Calif.—Topcon Healthcare, Inc., a global company specializing in digital health care solutions and robotic diagnostics, has announced the appointment of Daniela Ferrara, MD, Ph.D., as chief medical officer. In this role, Dr. Ferrara will lead the company’s clinical and medical strategy, helping to guide the development and implementation of solutions that improve the…EYECAREApr 29 2025
EyeMD EMR Healthcare Systems Announces Growth Investment From Performant CapitalCHICAGO—EyeMD EMR Healthcare Systems, Inc., a health care technology software solutions provider for ophthalmologists and eyecare specialists, has announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses.EYECAREApr 29 2025
Deadline Extended to May 12 to Submit Entries for VM's Annual Top 50 U.S. Optical Retailers ReportNEWARK, N.J.—Vision Monday has announced a deadline extension until Monday, May 12 at 11:59 p.m. ET, to submit information to its annual Top 50 U.S. Optical Retailers Report. Slated for publication in VM's upcoming June print/digital edition this year, VM's annual survey of regional and national retailers will collect and present sales and operations data…EYECAREApr 29 2025
U.S. at Tipping Point for Return of Endemic MeaslesThe United States is at a tipping point for the return of endemic measles a quarter century after the disease was declared eradicated in the country, researchers warned on Thursday.EYECAREApr 28 2025
Questions You Should Ask at Every Doctor's VisitPeople who are actively involved in their own health care tend to be healthier overall and have better outcomes when they do get sick. Having the knowledge, skills, beliefs and confidence to manage your health can help you prevent health problems and avoid risky behaviors.EYECAREApr 28 2025
Pharma Tariffs Would Raise U.S. Drug Costs by $51 Billion Annually, Report FindsA 25 percent U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9 percent if passed on, a report commissioned by the industry’s U.S. trade group and reviewed by Reuters shows.EYECAREApr 28 2025
VSP Vision and MATTER Launch Second Innovation Challenge to Source and Advance Solutions Enhancing EyecareRANCHO CORDOVA, Calif.—VSP Vision, a leader in health-focused vision care, and MATTER, a health care incubator and innovation hub, announced the launch of the second annual VSP Vision Innovation Challenge, a global competition to source and advance solutions enhancing the eyecare experience. The competition is co-hosted by MATTER and the VSP Global Innovation Center (GIC),…EYECAREApr 28 2025
NECO Names Lindsay Allen as Director of Development and Alumni RelationsBOSTON—The New England College of Optometry (NECO) has announced the appointment of Lindsay Allen as director of development and alumni relations.EYECAREApr 28 2025
GoodVision’s Global Vision Care Footprint Expands Into NepalNEWTON, Mass.—GoodVision USA, a nonprofit organization dedicated to improving lives in developing countries by providing high-quality and affordable vision care, has announced a new partnership with the Tilganga Institute of Ophthalmology, launching an initiative to bring essential eyecare services to underserved rural communities across Nepal.EYECAREApr 28 2025
U.S. May Have Millions More Measles Cases Over Next 25 Years if Childhood Vaccination Rates Continue to Decline, Study SaysMeasles could become endemic in the United States if routine childhood vaccination rates continue to decline, with up to 51 million illnesses over a 25-year period, according to a new study.EYECAREApr 25 2025
FDA Clears Luminopia for Amblyopia in Children Aged 8 to 12 Years OldThe FDA cleared Luminopia, a virtual reality-based therapeutic for amblyopia, for use in children aged 8 to 12 years old, adding to its existing approval in children aged 4 to 7 years old, according to a press release.EYECAREApr 25 2025
HPV May Be Linked to Thyroid Eye Disease, Small Study SuggestsA small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease (TED). A homology analysis of 11 patients with TED and 11 controls pinpointed conserved motifs shared by thyroid-stimulating hormone receptor (TSHR) and insulin-like growth factor-1 receptor (IGF-1R) with the HPV18 L1 capsid protein.EYECAREApr 25 2025
Bausch + Lomb Is Returning enVista Intraocular Lenses to Market Following Voluntary RecallVAUGHAN, Ontario—Approximately one month after a voluntary recall of intraocular lenses (IOLs) on its enVista platform, global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced that it has identified the event that led to the recall, and, now that the cause and affected lots have been confirmed, the company will be returning…EYECAREApr 25 2025
NECO Unveils Five-Year Strategic Plan: ‘The Future InSight’BOSTON—The New England College of Optometry (NECO) has announced the launch of its strategic 2025-2030 plan, The Future InSight, a five-year roadmap and comprehensive plan that the school emphasized is designed to revolutionize optometric education, clinical training, research and institutional sustainability. Building on the school’s legacy as the oldest continuously operating college of optometry in…EYECAREApr 25 2025
The Vision Council’s Focused inSights Report Explores AI Use in the Optical IndustryALEXANDRIA, Va.—The Vision Council’s inSights Research Program has released a new report that explores the expanding role of artificial intelligence (AI) in the eyewear and eyecare sectors. Drawing on interviews with AI experts across the industry, the report examines how organizations are already using AI, as well as its potential role in transforming the future…EYECAREApr 25 2025
STAAR Surgical Announces Changes to Its Board of DirectorsLAKE FOREST, Calif.—STAAR Surgical Company, a developer of implantable phakic intraocular lenses, has announced changes to its board of directors. The board has appointed Louis E. Silverman, who served on the company’s board from 2014-2022, as a director, effective April 24, 2025.EYECAREApr 25 2025
SUNY Optometry Researcher Publishes Study on Children’s Eye DevelopmentNEW YORK—SUNY College of Optometry announced that Jingyun Wang, Ph.D., associate professor and director of the school’s Pediatric Vision Research Lab, has published a landmark study examining the developmental patterns of eye growth in children with accommodative esotropia, a common form of childhood eye crossing associated with farsightedness.EYECAREApr 25 2025
Sight Sciences Announces the Release of its Sustainability ReportMENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, has announced the publication of its annual sustainability report, highlighting the company’s sustainability activities, performance and results from the last three years. The sustainability report includes information on the company’s environmental initiatives, including details on efforts to reduce its environmental footprint through energy efficiency,…EYECAREApr 25 2025
U.S. Chamber of Commerce Sets Small Business Day 2025 for May 1NEWARK, N.J.—The U.S. Chamber of Commerce announced that it has invited small business owners to join them on May 1, 2025, for Small Business Day 2025, a day of deep learning and in-person networking at its next event in Washington, D.C. The group will be kicking off Small Business Month alongside business experts and entrepreneurs…EYECAREApr 24 2025
Tick Season Is Back, But New Lyme Treatment Is on the HorizonTick season is back, and so is the threat of Lyme disease, with cases expected to climb yet again as climate change fuels tick activity. But two new studies point to new treatment options on the horizon: Researchers have identified new strategies that could make it easier to stop infection early and also reduce the…EYECAREApr 24 2025
Whooping Cough Cases Are Rising Again in the U.S., Challenging Health DepartmentsWhooping cough cases are rising, and doctors are bracing for yet another tough year.EYECAREApr 24 2025
EssilorLuxottica Reports Revenue Growth in First Quarter of 2025 Across All Regions, Will Implement Measures to Manage Impact of U.S. TariffsPARIS—EssilorLuxottica (Euronext: EL) announced its 2025 first quarter results on Wednesday for the period ending March 31, 2025, reporting that consolidated revenue for the first quarter of 2025 reached €6,848 million, representing a year-on-year increase of 7.3 percent at constant exchange rates compared with the first quarter of 2024 (+8.1 percent at current exchange rates).…EYECAREApr 24 2025
Aurion Biotech Announces Two Key Leadership AppointmentsSEATTLE, CAMBRIDGE, Mass. and TOKYO—Aurion Biotech, a clinical-stage regenerative medicine company focused on developing therapies for ocular diseases, has announced the appointments of Edward J. Holland, MD, as chief medical officer, and Eris P. Jordan, OD, as chief development officer.EYECAREApr 24 2025
The Ice Bucket Challenge Worked. Why Not Try It Again?Is it déjà vu or have we seen this trend before? It’s not just you. The Ice Bucket Challenge, which took over social media a decade ago, has found new life thanks to a group of college students who copied the concept, in its entirety, to spread mental health awareness.EYECAREApr 23 2025
FDA Approves Dupixent for Chronic Skin ConditionThe FDA just approved the popular drug Dupixent for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular allergy meds don't do the trick.EYECAREApr 23 2025
The Vision Council Advocates for the Vision Industry During White House MeetingALEXANDRIA, Va.—The Vision Council announced yesterday that, against the backdrop of ongoing concerns regarding the impact of tariffs on the optical industry, representatives from the organization had met on April 21 with Robin Colwell, deputy assistant to President Trump and deputy director of the National Economic Council, at the White House. At the meeting, representatives…EYECAREApr 23 2025
Hoya Vision Care Partners With Seneca Polytechnic to Launch Innovative Opticianry LabTORONTO—Opticianry students at Seneca Polytechnic now have access to a cutting-edge optical laboratory, thanks to a new gift from Hoya Vision Care, the school announced.EYECAREApr 23 2025
Review of Myopia Management: Understanding Myopia Management—A Journey From Patient to PractitionerOver the course of the last decade, my optometry training has taken me from Singapore to Australia. Regardless of where I’ve landed, one thing that’s been consistent from day one is my passion for helping myopic patients. Being a high myope, I understand what it’s like to wear glasses since I was 10 years old.…EYECAREApr 22 2025
Women Don't Want AI as Sole Reader of Breast Cancer ScreeningsFew women wanted artificial intelligence (AI) as the sole reader of their screening mammograms, according to a survey, though most respondents generally supported some use of the technology.EYECAREApr 22 2025
More Pharmacies Offer to Speed Prescription Deliveries to CustomersAmerica's two largest retailers want to deliver prescriptions to your doorstep in as little as a few hours.EYECAREApr 22 2025
Neurotech Pharmaceuticals Appoints Beth Marsh as Chief Commercial OfficerCUMBERLAND, R.I.—Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing therapies for chronic eye diseases, has announced the appointment of Beth Marsh as chief commercial officer, effective April 28. In this role, Marsh will lead the commercial organization, including preparing for the U.S. launch of Encelto (revakinagene taroretcel-lwey), an approved treatment for adults with…EYECAREApr 22 2025
Bausch + Lomb Collects More than 100 Million Units of Eyecare Products Through Its Two Recycling ProgramsVAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company has announced that the company’s One by One Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units, or 625,026 pounds of used contact lenses, eyecare and lens care materials in the United States, the equivalent to the…EYECAREApr 22 2025
Deadline Extended to Submit Entries for VM's Annual Top 50 U.S. Optical Retailers ReportNEWARK, N.J.—Vision Monday has announced a deadline extension until Tuesday, April 29, to submit information to its annual Top 50 U.S. Optical Retailers Report. Slated for publication in VM's upcoming June print/digital edition this year, VM's annual survey of regional and national retailers will collect and present sales and operations data for the calendar year…EYECAREApr 22 2025
The Centre for Ocular Research & Education Launches SustainableEyecare.comWATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) at the University of Waterloo has announced the launch of SustainableEyecare.com, a website designed to educate eyecare professionals and patients about the environmental impact of contact lenses and eyewear and provide practical solutions for recycling and responsible disposal.EYECAREApr 22 2025
Review of Optometry: Decoding the Keratoconus MatrixStandard of care in keratoconus (KC) management has changed similarly to glaucoma: we promptly treat the disease because of expanding treatment options and diagnostic tools that enable earlier detection. As an example, visual field loss was the hallmark of glaucoma, but now ganglion cell loss is routinely used for early diagnosis. Like glaucoma, the ultimate…EYECAREApr 21 2025
Here's How to Use Nasal Spray Right and More Tips for Managing Spring AllergiesIf you feel like your seasonal allergies are getting worse every year, it's not just you. Warming from climate change is making the pollen season longer, and more people are going to the doctor each year looking for relief, according to a recent research review published in the journal The Laryngoscope.EYECAREApr 21 2025
We May Soon Have a Blood Test to Predict Postpartum DepressionPostpartum depression is the most common complication of childbirth, affecting about 1 in 7 women after delivery. It causes bouts of severe depression and anxiety, makes bonding with a newborn especially difficult, and can lead to thoughts of self-harm. Suicide is a leading cause of maternal death in the United States.EYECAREApr 21 2025
FDA Authorizes First Prescription Digital Therapeutic for MigraineThe U.S. Food and Drug Administration (FDA) has granted marketing authorization to CT-132 (Click Therapeutics), an adjunctive, first-in-class prescription digital therapeutic for the preventive treatment of episodic migraine in adults, its development company announced in a statement.EYECAREApr 21 2025
Candidates Announce Bids for AOA’s 2025 Board of Trustees ElectionST. LOUIS—The American Optometric Association has provided its members with updated information on the eyecare professionals—both incumbents and newcomers—who are seeking to be elected to new positions on the association’s Board of Trustees. Six doctors of optometry are vying for positions on the board. The new board will be elected in June at the annual…EYECAREApr 21 2025
ASCRS Annual Meeting Will Kick Off in Los Angeles From April 25-28LOS ANGELES—The American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, the largest U.S. meeting dedicated to anterior segment surgery, will take place here from April 25–28.EYECAREApr 21 2025
Oculis and EURETINA Announce Applications Are Now Open for the 2025 Ramin Tadayoni AwardZUG, Switzerland—Oculis Holding AG, a global biopharmaceutical company developing solutions for ophthalmic and neuro-ophthalmic diseases, has announced, in collaboration with the European Society of Retina Specialists (EURETINA), the 2025 Ramin Tadayoni Award.EYECAREApr 21 2025
Jobson Optical Research Report Examines ECPs’ Use of Digital SolutionsNEWARK, N.J.—In December 2024, Jobson Optical Research surveyed eyecare professionals on their use of digital solutions. The 42-page report features insights on what type of social media presence optical locations use and the frequency of posting.EYECAREApr 21 2025
Lilly Says Daily Pill Can Lower Blood Sugar and Weight in People With Type 2 DiabetesA daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company announced Thursday.EYECAREApr 18 2025
U.S. has 800 Measles Cases and Outbreaks in Several StatesThe U.S. has 800 cases of measles nationwide as of Friday, and two more states identified outbreaks this week.EYECAREApr 18 2025
Hearing Loss May Play a Bigger Role in Dementia Than Previously ThoughtHearing loss may play a bigger role in dementia than previously thought, data from a U.S. cohort study suggested.EYECAREApr 18 2025
PECAA Annual Meeting Convenes Record Number of Doctors to Explore the Power of StorytellingBOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA), a community of independent eyecare professionals, hosted approximately 900 private practice professionals, strategic vendor partners and industry leaders at its annual meeting April 9–11, with a record number of doctors present. Held in Orlando, PECAA’s 16th annual signature event included peer networking and collaboration, keynotes, education…EYECAREApr 18 2025
The Vision Council Consumer inSights Q1 2025 Report Shows Signs of Increased Consumer Spending on Vision Care ProductsALEXANDRIA, Va.—The Vision Council released new research this week exploring consumer trends across optical products and services for the first quarter of 2025. The report, titled Consumer inSights Q1 2025, highlights the views and behaviors of U.S. adults as it relates to vision correction, managed vision care, eye exams, prescription eyewear, reading glasses and non-prescription…EYECAREApr 18 2025
CooperVision Reaches Half-Billion Bottle Milestone in Net Plastic Neutrality InitiativeROCHESTER, N.Y.—CooperVision, a division of CooperCompanies and a leading manufacturer of contact lenses, announced it has reached a significant milestone in its pioneering net plastic neutrality initiative.EYECAREApr 18 2025
BVI Medical Receives FDA 510(k) Clearance for Next-Generation Glaucoma Surgical SystemWALTHAM, Mass.—BVI Medical, a global ophthalmic device company, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its glaucoma surgical system, Leos (Laser Endoscopy Ophthalmic System).EYECAREApr 18 2025
Women In Optometry's Special 10th Anniversary Theia Award Nominations Are Now OpenNEWARK, N.J.—Nominations are now open for the 2025 Women In Optometry Theia Awards of Excellence. Over the past nine years, Women In Optometry has celebrated the 62 winners of these annual awards, and this year, for the 10th anniversary, the nominations will include one special honor, a Lifetime of Leadership award. Nominations are now open…EYECAREApr 18 2025
Autism Rates Hit Record High, CDC Data ShowU.S. autism rates reached a record high, with about one in 31 children identified with autism spectrum disorder (ASD) in 2022, new CDC data suggested.EYECAREApr 17 2025
5 Risk Factors at 50 Can Steal a Decade of LifeFive classic risk factors for cardiovascular disease—high blood pressure, high cholesterol, obesity, diabetes, and smoking—at age 50 can reduce life expectancy by more than 10 years. This is the conclusion of an international study led by German researchers and presented at the 2025 American College of Cardiology Scientific Session.EYECAREApr 17 2025
Behind the Cortisol Trend: Misinformation Could Drive Unnecessary TestingEYECAREApr 17 2025
The Vision Council's Latest Webinar Offers Strategic Planning Tips Under New TariffsNEWARK, N.J.—In an ongoing effort to keep its membership updated on how the Trump Administration tariffs are affecting the optical industry, yesterday The Vision Council held its latest in a series of tariff-related webinars. While previous webinars from the group focused on the changing tariff rates and costs associated with them, yesterday’s session addressed the…EYECAREApr 17 2025
Fittingbox and Ocuco Renew Partnership to Deliver Digital Solutions for Eyecare ProfessionalsTOULOUSE, France and DUBLIN, Ireland—Fittingbox, a developer of eyewear virtual try-on and glasses digitization, and Ocuco, a global provider of optical software solutions, have announced the renewal of their partnership. Since first partnering in 2018, the companies have combined their expertise to deliver omnichannel solutions for eyecare professionals. This collaboration integrates Fittingbox’s advanced eyewear visualization…EYECAREApr 17 2025
Prevent Blindness Contends West Virginia State House Bill Would Imperil Children’s VisionCHICAGO—Prevent Blindness, a nonprofit eye health organization, announced that it is calling on the West Virginia State House to reject HB 3444, which proposes the repeal of four sections of the West Virginia Code that pertain to the inflammation of the eyes in newborns. If enacted, Prevent Blindness said the legislation would remove the mandate…EYECAREApr 17 2025
Glaukos Releases Its 2024 Sustainability ReportALISO VIEJO, Calif.—Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company developing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced that it has published its 2024 Sustainability Report.EYECAREApr 17 2025
20/20 Onsite Recognized by TITAN Health Awards for Transforming Health Care Through Patient-Centric, Ophthalmic AssessmentsBOSTON—20/20 Onsite, a health care services company that utilizes Mobile Vision Clinics to deliver vision care services, announced that it has been named a Silver Winner in the 2025 TITAN Health Awards in the category of Provider and Services - Healthcare for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments.EYECAREApr 17 2025
Systematic review of clinical practice guidelines for the management of neovascular age-related macular degeneration Eye, Published online: 15 May 2025; doi:10.1038/s41433-025-03829-8Systematic review of clinical practice guidelines for the management of neovascular age-related macular degenerationEyeMay 15 2025
Correlation of retino-choroidal thickness and vascular metrics with drusen volume as a severity marker of age-related macular degeneration Eye, Published online: 15 May 2025; doi:10.1038/s41433-025-03847-6Correlation of retino-choroidal thickness and vascular metrics with drusen volume as a severity marker of age-related macular degenerationEyeMay 15 2025
A review of selection criteria for ophthalmology training in the Western world Eye, Published online: 15 May 2025; doi:10.1038/s41433-025-03850-xA review of selection criteria for ophthalmology training in the Western worldEyeMay 15 2025
Retinal optical coherence tomography angiography (OCTA) biomarkers of cardiovascular disease: a review articleEye, Published online: 14 May 2025; doi:10.1038/s41433-025-03780-8Retinal optical coherence tomography angiography (OCTA) biomarkers of cardiovascular disease: a review articleEyeMay 14 2025
In vivo analysis of iridocorneal angle parameters with spectral-domain optical coherence tomography in children with Neurofibromatosis type 1Eye, Published online: 14 May 2025; doi:10.1038/s41433-025-03840-zIn vivo analysis of iridocorneal angle parameters with spectral-domain optical coherence tomography in children with Neurofibromatosis type 1EyeMay 14 2025
Optic disc morphology in congenital glaucomaEye, Published online: 14 May 2025; doi:10.1038/s41433-025-03839-6Optic disc morphology in congenital glaucomaEyeMay 14 2025
Hybrid closed loop devices: The utility of continuous glucose monitoring metrics for retinal surveillance during transition from standard insulin pumpEye, Published online: 13 May 2025; doi:10.1038/s41433-025-03834-xHybrid closed loop devices: The utility of continuous glucose monitoring metrics for retinal surveillance during transition from standard insulin pumpEyeMay 13 2025
Causal relationships between depression, anxiety, and myopia: a two-sample Mendelian randomization studyEye, Published online: 13 May 2025; doi:10.1038/s41433-025-03841-yCausal relationships between depression, anxiety, and myopia: a two-sample Mendelian randomization studyEyeMay 13 2025
Honeycomb corneal oedema after rho-kinase inhibitor useEye, Published online: 12 May 2025; doi:10.1038/s41433-025-03842-xHoneycomb corneal oedema after rho-kinase inhibitor useEyeMay 12 2025
Steatocystoma of the EyelidEye, Published online: 12 May 2025; doi:10.1038/s41433-025-03820-3Steatocystoma of the EyelidEyeMay 12 2025
Long-term outcomes of the observe-and-plan regimen in treating neovascular age-related macular degeneration: a retrospective real-life analysisEye, Published online: 10 May 2025; doi:10.1038/s41433-025-03830-1Long-term outcomes of the observe-and-plan regimen in treating neovascular age-related macular degeneration: a retrospective real-life analysisEyeMay 10 2025
Lower incidence of diabetic retinopathy and worsening events after phentermine assisted weight loss across a large U.S. cohortEye, Published online: 10 May 2025; doi:10.1038/s41433-025-03818-xLower incidence of diabetic retinopathy and worsening events after phentermine assisted weight loss across a large U.S. cohortEyeMay 10 2025
Association between leukocyte telomere length and incident glaucoma: A prospective UK biobank studyEye, Published online: 07 May 2025; doi:10.1038/s41433-025-03838-7Association between leukocyte telomere length and incident glaucoma: A prospective UK biobank studyEyeMay 07 2025
NAION risk with semaglutide: what we know so farEye, Published online: 07 May 2025; doi:10.1038/s41433-025-03833-yNAION risk with semaglutide: what we know so farEyeMay 07 2025
Diabetic foveal neovascularization is associated with diminished subfoveal choroidal flow on optical coherence tomography angiographyEye, Published online: 06 May 2025; doi:10.1038/s41433-025-03806-1Diabetic foveal neovascularization is associated with diminished subfoveal choroidal flow on optical coherence tomography angiographyEyeMay 06 2025
Endoresection of choroidal melanoma: practical and safety considerationsEye, Published online: 06 May 2025; doi:10.1038/s41433-025-03827-wEndoresection of choroidal melanoma: practical and safety considerationsEyeMay 06 2025
Response to: ‘Comment on: “Incidence of optic nerve kinking in a cohort of patients with Normal tension glaucoma”’Eye, Published online: 05 May 2025; doi:10.1038/s41433-025-03822-1Response to: ‘Comment on: “Incidence of optic nerve kinking in a cohort of patients with Normal tension glaucoma”’EyeMay 05 2025
Atypical retinitis pigmentosa associated with CERKL mutationEye, Published online: 05 May 2025; doi:10.1038/s41433-025-03815-0Atypical retinitis pigmentosa associated with CERKL mutationEyeMay 05 2025
Comment on: “Incidence of optic nerve kinking in a cohort of patients with Normal tension glaucoma”Eye, Published online: 05 May 2025; doi:10.1038/s41433-025-03821-2Comment on: “Incidence of optic nerve kinking in a cohort of patients with Normal tension glaucoma”EyeMay 05 2025
Afghanistan–Pakistan retinoblastoma “Silk Road” referral pathwayEye, Published online: 03 May 2025; doi:10.1038/s41433-025-03823-0Afghanistan–Pakistan retinoblastoma “Silk Road” referral pathwayEyeMay 03 2025
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)Eye, Published online: 03 May 2025; doi:10.1038/s41433-025-03813-2Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)EyeMay 03 2025
The aftermath of retinopathy of prematurity blindnessEye, Published online: 03 May 2025; doi:10.1038/s41433-025-03826-xThe aftermath of retinopathy of prematurity blindnessEyeMay 03 2025
High-altitude retinopathy - a potential model for retinal haemorrhages in suspected shaken baby syndromeEye, Published online: 02 May 2025; doi:10.1038/s41433-025-03824-zHigh-altitude retinopathy - a potential model for retinal haemorrhages in suspected shaken baby syndromeEyeMay 02 2025
Generative AI in clinical practice: novel qualitative evidence of risk and responsible use of Google’s NotebookLMEye, Published online: 02 May 2025; doi:10.1038/s41433-025-03817-yGenerative AI in clinical practice: novel qualitative evidence of risk and responsible use of Google’s NotebookLMEyeMay 02 2025
Non-inferiority trials in clinical ophthalmology: a systematic reviewEye, Published online: 01 May 2025; doi:10.1038/s41433-025-03819-wNon-inferiority trials in clinical ophthalmology: a systematic reviewEyeMay 01 2025
Characteristics of orbital lymphoproliferative disorders: a retrospective study of 84 casesEye, Published online: 30 April 2025; doi:10.1038/s41433-025-03816-zCharacteristics of orbital lymphoproliferative disorders: a retrospective study of 84 casesEyeApr 30 2025
Diagnostic utility of artificial intelligence software through non-mydriatic digital retinography in the screening of diabetic retinopathy: an overview of reviewsEye, Published online: 29 April 2025; doi:10.1038/s41433-025-03809-yDiagnostic utility of artificial intelligence software through non-mydriatic digital retinography in the screening of diabetic retinopathy: an overview of reviewsEyeApr 29 2025
The effect of glucagon-like peptide-1 agonists on ocular parameters in idiopathic intracranial hypertension patients: a retrospective studyEye, Published online: 29 April 2025; doi:10.1038/s41433-025-03807-0The effect of glucagon-like peptide-1 agonists on ocular parameters in idiopathic intracranial hypertension patients: a retrospective studyEyeApr 29 2025
Axial length as a predictor of myopic macular degeneration: a meta-analysis and clinical studyEye, Published online: 25 April 2025; doi:10.1038/s41433-025-03782-6Axial length as a predictor of myopic macular degeneration: a meta-analysis and clinical studyEyeApr 25 2025
Bitot’s spot without hypovitaminosis AEye, Published online: 25 April 2025; doi:10.1038/s41433-025-03812-3Bitot’s spot without hypovitaminosis AEyeApr 25 2025
Correction: An education-based intervention investigating the accuracy of community-based optometrists evaluating limbal anterior chamber depthEye, Published online: 25 April 2025; doi:10.1038/s41433-025-03810-5Correction: An education-based intervention investigating the accuracy of community-based optometrists evaluating limbal anterior chamber depthEyeApr 25 2025
Ophthalmology during conflict: a vitreoretinal surgeon’s journey in GazaEye, Published online: 24 April 2025; doi:10.1038/s41433-025-03802-5Ophthalmology during conflict: a vitreoretinal surgeon’s journey in GazaEyeApr 24 2025
Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021Eye, Published online: 23 April 2025; doi:10.1038/s41433-025-03786-2Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021EyeApr 23 2025
A novel and effective ophthalmology morbidity and mortality meeting: eight years of learning and improvementEye, Published online: 23 April 2025; doi:10.1038/s41433-025-03811-4A novel and effective ophthalmology morbidity and mortality meeting: eight years of learning and improvementEyeApr 23 2025
Bilateral cataract and macular coloboma in thiamine-responsive megaloblastic anemiaEye, Published online: 22 April 2025; doi:10.1038/s41433-025-03713-5Bilateral cataract and macular coloboma in thiamine-responsive megaloblastic anemiaEyeApr 22 2025
The varieties of junctional scotoma: 17 cases, a review, and a taxonomyEye, Published online: 22 April 2025; doi:10.1038/s41433-025-03789-zThe varieties of junctional scotoma: 17 cases, a review, and a taxonomyEyeApr 22 2025
Updates on novel and traditional OCT and OCTA biomarkers in nAMDEye, Published online: 19 April 2025; doi:10.1038/s41433-025-03801-6Updates on novel and traditional OCT and OCTA biomarkers in nAMDEyeApr 19 2025
Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parametersEye, Published online: 17 April 2025; doi:10.1038/s41433-025-03804-3Outcomes of laser peripheral iridotomy in subgroups of primary angle closure disease eyes according to swept-source optical coherence tomography parametersEyeApr 17 2025
VA and Complications After Bilateral Secondary Intraocular Lens Implantation for Pediatric Aphakia This cohort study analyzes differences in visual acuity (VA) and complication rates among children with bilateral aphakia who underwent secondary intraocular lens implantation at different ages.JAMA Ophthalmology Online FirstMay 15 2025
Encouraging News for Children With Aphakia Aphakic and pseudophakic glaucomas associated with infant cataracts remain vexing problems. The risk for developing glaucoma is probably lifelong and is high. Despite a few hopeful studies, one suggesting that delaying surgery in congenital cataracts until after 3 months of age reduces the risk of glaucoma, the risk for glaucoma remains high. The surgeon’s dilemma…JAMA Ophthalmology Online FirstMay 15 2025
Application of Artificial Intelligence to Deliver Healthcare From the EyeThis Special Communication discusses Healthcare From the Eye prescreening, a combination of artificial intelligence analysis of ocular data with automated technologies captured during routine eye examinations to transform health care delivery and improve early disease detection, improve access to care, and reduce costs.JAMA Ophthalmology Online FirstMay 08 2025
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA TestThis cross-sectional study identifies and characterizes RB1 mosaicism in patients with retinoblastoma using a clinical assay that combines plasma cell-free DNA (cfDNA) testing and buffy coat genomic DNA testing.JAMA Ophthalmology Online FirstMay 08 2025
Characterization of Belantamab Mafodotin–Induced Corneal Changes in Patients With Multiple MyelomaThis case series study characterizes corneal epithelial changes in patients with relapsed or refractory multiple myeloma treated with belantamab mafodotin, an antibody-drug conjugate.JAMA Ophthalmology Online FirstMay 08 2025
Corneal Changes From Antibody-Drug ConjugatesOver the last 2 decades, the number of targeted anticancer drugs has grown at an exponential pace. However, with these rapid advances in cancer treatment, an evolving landscape of ocular adverse events (AE) has emerged, necessitating strengthened cooperative efforts among ophthalmologists, pathologists, hematologist-oncologists, and pharmacologists. Lee and colleagues have exemplified the power of such multidisciplinary…JAMA Ophthalmology Online FirstMay 08 2025
DNA Assays to Detect and Characterize RB1 Mosaicism in RetinoblastomaMosaicism is the presence of 2 or more clonal cell lines that result from a mutational process in a postconceptional fertilized egg. The affected cells may be somatic (any cell type including retina) or germinal (oocyte or sperm). If somatic alone, the mutation may not be inherited by the offspring; however, if this is both…JAMA Ophthalmology Online FirstMay 08 2025
Noninfectious Intraocular Inflammation After Intravitreal AfliberceptThis case series analyzes data from patients given aflibercept, 2 mg, for neovascular age-related macular degeneration and diabetic macular edema to determine the incidence in clinical practice of intraocular inflammation.JAMA Ophthalmology Online FirstMay 01 2025
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023This cohort study assesses whether ophthalmology resident trainees who are underrepresented in medicine (URiM) reported equivalent surgical experiences to non-URiM trainees in the same cohort.JAMA Ophthalmology Online FirstMay 01 2025
Training Inequities in Ophthalmology—Insights From EducatorsWe commend Culican and colleagues as the first investigators to date to obtain Accreditation Council for Graduate Medical Education (ACGME) case logs for 100% of residents in a specialty to assess for gender and racial and ethnic disparities in surgical volume of trainees. By analyzing case logs from more than 4000 graduates of all ACGME-accredited…JAMA Ophthalmology Online FirstMay 01 2025
Cone Density Changes After Red Light Treatment in Children With MyopiaThis cohort study investigates detectable changes in cone density after repeated low-level red light therapy to control myopia in children.JAMA Ophthalmology Online FirstApr 24 2025
Repeated Low-Level Red Light—More Than Meets the Eye?Liao and colleagues present an interesting report of high-resolution retinal images from children treated with repeated low-level red light (RLRL) for at least 12 months. The article is important, because myopia and myopic degeneration are increasing in prevalence throughout the world, and recent research has suggested that exposure to red light during childhood may counter…JAMA Ophthalmology Online FirstApr 24 2025
Scientific Data Fabrication and AI—Pandora’s BoxSince the advent of OpenAI’s large language model (LLM) ChatGPT in 2022, LLMs have been used to take Ophthalmic Knowledge Assessment Program examinations, create ophthalmic scientific abstracts, and manage glaucoma and retina clinical scenarios, among other impressive feats. The study in this issue of JAMA Ophthalmology by Taloni et al demonstrated the ability of ChatGPT…JAMA Ophthalmology Online FirstApr 24 2025
Human Papillomavirus and Thyroid Eye DiseaseThis case-control study conducted among 22 patients at the Bascom Palmer Eye Institute in Miami, Florida, explores the potential involvement of viral infections in thyroid eye disease pathogenesis.JAMA Ophthalmology Online FirstApr 24 2025
Detection Methods for Synthetic Datasets Created With a Large Language ModelThis quality improvement study investigates the limits of generative artificial intelligence by using a large language model to create synthetic datasets and forensic analysis to identify statistical patterns that may suggest fabrication.JAMA Ophthalmology Online FirstApr 24 2025
Phacogoniotomy vs Phacotrabeculectomy in Advanced PACG With CataractThis secondary analysis of the Phacogoniotomy vs Phacotrabeculectomy (PVP) randomized clinical trial investigates if intraocular pressure reduction with phacogoniotomy is noninferior to phacotrabeculectomy in advanced primary angle-closure glaucoma (PACG) with cataract.JAMA Ophthalmology Online FirstApr 17 2025
Is Phacogoniotomy the Best Surgery for PACG and Cataract?Song et al report similar (specifically, noninferior) outcomes at 2 years in a randomized clinical trial comparing phacoemulsification cataract extraction with goniosynechialysis and goniotomy (PGG) with phacoemulsification and trabeculectomy (PT) in patients with primary angle-closure glaucoma (PACG) and elevated intraocular pressure (IOP). Safety did not appear to be substantially different between the 2 groups, although,…JAMA Ophthalmology Online FirstApr 17 2025
Peripheral Iridectomy With Goniosynechialysis and Goniotomy vs Trabeculectomy for Advanced PACGThis randomized clinical trial conducted at 8 tertiary eye centers in China investigates the safety and effectiveness at 1 year of surgical peripheral iridectomy with goniosynechialysis and goniotomy vs trabeculectomy in advanced primary angle-closure glaucoma (PACG) without cataract.JAMA Ophthalmology Online FirstApr 17 2025

© ECM All rights reserved 2025.